Stockreport

ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF strong contributions from its rare disease portfolio, particularly Purified Cortrophin Gel. The company also outlined plans to hire roughly 90 additional rare disease [Read more]